Elovac Hepatitis B vaccine

In the last few years we have established ourselves as one of the most prominent organizations engaged in offering Elovac Hepatitis B Vaccine. It is indicated for active immunization against Hepatitis B infection in subjects considered at risk of exposure to HBV positive material. The vaccine is recommended for neonates, infants, children and adolescents upto 19 years of age. It is produced by recombinant DNA technology, most commonly in yeast. Elovac Hepatitis B Vaccine can be used in effectively protecting people who receive liver transplants, as well as infants born to the mothers who are already infected with Hepatitis B.